Differentiation Therapy of Leukemia

References

• Sachs L. Control of normal differentiation and the pheno-typic reversion of malignancy in myeloid leukemia cells. Nature 1978; 274: 535
   PubMed Web of Science ®Google Scholar
• Housset M., Daniel M. T., Degos L. Small doses of ARA-C in the treatment of acute myeloid leukemia: differentiation of myeloid leukemia cells?. Brit. J. Haematol. 1982; 51: 125–129
   PubMed Web of Science ®Google Scholar
• Tilly H., Castaigne S., Bordessoule D., Casassus P., Le Prise P. Y., Tertian G., Desablens B., Henry-Amar M., Degos L. Low-dose cytarabine versus intensive chemotherapy in the treatment of acute nonlymphocytic leukemia in the elderly. J. Clin. Oncol. 1990; 8: 272–279
   PubMed Web of Science ®Google Scholar
• Chomienne C., Ballerini P., Balitrand N., Daniel M. T., Fenaux P., Castaigne S., Degos L. All trans retinoie acid in acute promyelocytic leukemia. II. In vitro studies: structure function relationship. Blood 1990; 76: 1710–1717
   PubMed Web of Science ®Google Scholar
• Castaigne S., Chomienne C., Daniel M. T., Ballerini P., Berger R., Fenaux P., Degos L. All trans retinoie acid as a differentiation therapy for acute promyelocytic leukemia. I. Clinical results. Blood 1990; 76: 1704–1709
   PubMed Web of Science ®Google Scholar
• Wang Z. Y., Degos L. (1993) Retinoie acid in hematological malignancies. International Symposium, Shanghai, Chine, Octobre, 19–211993
   Google Scholar
• Dombret H., Sutton L., Duarte M., Daniel M. T., Leblond V., Castaigne S., Degos L. Combined therapy with all-trans retinoie acid and high-dose chemotherapy in patients with hyper-leukocytic acute promyelocytic leukemia and severe visceral hemorrhage. Leukemia 1992; 6: 1237–1242
   PubMed Web of Science ®Google Scholar
• Frankel S. R., Eardley A., Lauwers G., Weiss M., Warrell R. P. The “retinoie acid syndrome” in acute promyelocytic leukemia. Ann. Intern. Med. 1992; 117: 292–296
   PubMed Web of Science ®Google Scholar
• Castaigne S., Lefebvre P., Chomienne C., Sue E., Rigal-Huguet F., Gardin C., Delmer A., Archimbaud E., Tilly H., Janvier M., Isnard F., Travade P., Montfort L., Delannoy A., Rapp M. J., Christian G., Montastruc M., Weh H., Fenaux P., Dombret H., Gourmel B., Degos L. Effectiveness and pharmacokinetics of low-dose all-trans retinoie acid (25 mg/m2) in acute promyelocytic leukemia. Blood 1993, (in press)
   Web of Science ®Google Scholar
• Warrell R. P., Muindi J., Frankel S. R., Jakubowski A., Dmitrovsky E., Miller W. H. Continuous treatment with all trans retinoie acid progressively decreases plasma drug concentrations: implications for relapse and resistance in acute promyelocytic leukemia. Blood 1991; 268a, (ASH abstract) abst n† 1063
   Google Scholar
• Muindi J. F., Young C. W. Lipid hydroperoxides greatly increase the rate of oxidative catabolism of all-trans retinoie acid by human cell culture microsomes genetically enriched in specified cytochrome P-450 isoforms. Cancer Res. 1993; 53: 1226–1229
   PubMed Web of Science ®Google Scholar
• Cornic M., Delva L., Guidez F., Balitrand N., Degos L., Chomienne C. Induction of retinoie acid binding protein in normal and malignant human myeloid cells by retinoie acid in AML3 patients. Cancer Res. 1992, (in press)
   PubMed Web of Science ®Google Scholar
• Fenaux P., Castaigne S., Dombret H., Chomienne C., Duarte M., Archimbaud E., Lamy T., Tibeghien P., Tilly H., Dufour P., Cransac M., Guerci A., Sadoun A., Degos L. All-trans retinoie acid in newly diagnosed acute promyelocytic leukemia: a pilot study. Blood 1991; 79a, (ASH Abstract) Abst n† 305 (plenary session)
   Google Scholar
• Fenaux P., Castaigne S., Chomienne C., Dombret H., Archimbaud E., Duarte M., Lamy T., Tilly H., Guerci A., Maloisel P., Bordessoule D., Sadoun A., Tiberghien P., Fegueux N., Daniel M. T., Degos L. All-trans retinoie acid followed by intensive chemotherapy gives a high complete remission rate and prolonged remissions in new diagnosed acute promyelocytic leukemia. Blood 1993; 80: 2176–2181
   Web of Science ®Google Scholar
• Rowley J. D., Golomb H. M., Dougherty C. 15/17 translocation: a consistent chromosomal change in acute promyelocytic leukaemia. Lancer 1977; 1: 549–550
   PubMed Web of Science ®Google Scholar
• Chomienne C., Ballerini P., Balitrand N., Huang M. E., Krawice I., Castaigne S., Fenaux P., Tiollais P., Dejean A., Degos L., de The H. The retinoie acid receptor alpha gene is rearranged in retinoie acid sensitive promyelocytic leukemia. Leukemia 1990; 4: 802–807
   PubMed Web of Science ®Google Scholar
• de The H., Chomienne C., Lanotte M., Degos L., Dejean A. The t(15;17) translocation of acute promyelocytic leukemia fuses the retinoie acid receptor alpha gene to a novel transcribed locus. Nature 1990; 347: 558–561
   PubMed Web of Science ®Google Scholar
• Borrow J., Goddard A. D., Sheer D., Solomon E. Molecular analysis of acute promyelocytic leukemia breakpoint cluster region on chromosome 17. Science 1990; 249: 1577–1580
   PubMed Web of Science ®Google Scholar
• Castaigne S., Balitrand N., de The H., Dejean A., Degos L., Chomienne C. A PML/RAR alpha fusion transcript is constantly detected by RNA based polymerase chain reaction in acute promyelocytic leukemia. Blood 1992; 79: 3110–3115
   PubMed Web of Science ®Google Scholar
• De The H., Lavau C., Marchio A., Chomienne C., Degos L., Dejean A. The PLM-RAR fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR. Cell 1991; 66: 675–684
   PubMed Web of Science ®Google Scholar
• Kakizuka A., Miller W. H., Jr, Umesono K., et al. Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RAR alpha with a novel putative transcription factor, PML. Cell 1991; 66: 663–674
   PubMed Web of Science ®Google Scholar
• Pandolfi P. P., Grignani F., Alcalay M., et al. Structure and origin of the acute promyelocytic leukemia my1/RAR alpha cDNA and characterization of its retinoid-bind-ing and transactivation properties. Oncogene 1991; 6: 1285–1292
   PubMed Web of Science ®Google Scholar
• Rousselot P., Hardas B., Patel A., Guidez F., Gaken J., Castaigne S., Dejean A., de The H., Degos L., Farzaneh F., Chomienne C. The PML:RAR alpha gene product of the t(15;17) translocation inhibits retinoie acid induced differentiation and mediated transactivation in human myeloid cells. Oncogene 1993, (in press)
   Web of Science ®Google Scholar
• Chomienne C., Balitrand N., Ballerini P., Castaigne S., de The H., Degos L. All trans retinoie acid modulates the retinoie receptor alpha in promyelocytic cells. J. Clin. Invest. 1991; 88: 2150–2154
   PubMed Web of Science ®Google Scholar
• Daniel M. T., Koken M., Romagne O., Barbey S., Bazarbachi A., Stadler M., Guillemin M. C., Degos L., Chomienne C., de The H. PML protein expression in haematopoietic and APL cells. Blood 1993; 82: 1858–1867
   PubMed Web of Science ®Google Scholar